Last reviewed · How we verify
CArbosylane
CArbosylane is a carbohydrate-based therapeutic that modulates immune responses through glycan-mediated mechanisms.
At a glance
| Generic name | CArbosylane |
|---|---|
| Sponsor | University Hospital, Rouen |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
The drug appears to work by leveraging carbohydrate structures to engage pattern recognition receptors on immune cells, thereby modulating inflammatory and immune responses. This glycan-based approach may enhance or redirect immune function depending on the therapeutic target. The exact molecular mechanism remains proprietary to the University Hospital, Rouen research program.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |